Ion-Marc Valahu with Bloomberg – 01.10.2021
sys_clairinv2021-10-01T10:44:43+01:00Sanofi ditches mRNA COVID-19 vaccine after rivals' success "The decision to end RNA looks to be interpreted as positive since they will save development costs and concentrate on other products and ventures," said Ion-Marc Valahu, a fund manager at Geneva-based investment firm Clairinvest. Seven. 28 (National Post) -- PARIS - Sanofi is dropping plans [...]